Medical Glossary

Resection Margin — Tissue Edge Around a Tumour

A resection margin is the perimeter of healthy-looking tissue surgically removed along with a tumour. When examined under a microscope by a pathologist, the condition of this margin reveals whether the cancer was completely excised or if malignant cells may have been left behind at the surgical boundary.

4 min readLast reviewed August 1, 2026Medically reviewed by: GetOnco Medical Review Team

In simple terms

When a surgeon cuts out a tumour, they deliberately remove a thin layer of surrounding normal tissue as a safety buffer. That outer rim is the resection margin. In the laboratory, a pathologist colours the edges with special ink and examines them under a microscope. If no cancer cells are touching the ink, it is called a 'clear' or 'negative' margin. If cancer cells do reach the ink, it is a 'positive' margin, which means some cancer may still be inside the body.

Key takeaways

  • Negative (clear) margins indicate no cancer cells were detected at the outer edge of the removed specimen.
  • Positive margins mean cancer cells touch the inked edge, implying residual cells might remain.
  • Pathologists use microscopic evaluation and tissue-marking ink to measure margins accurately in millimetres.
  • Positive margins often necessitate re-operation, targeted radiotherapy, or adjusted systemic therapy.

Definition

Pathologists classify resection margins using standardised macroscopic and microscopic assessments. A negative margin (or 'clear margin') signifies that no cancer cells are present at the outermost boundary of the excised tissue. This finding provides confidence that the visible tumour has been completely removed with an acceptable rim of normal tissue.

A positive margin occurs when malignant cells extend directly to the inked outer edge of the specimen, indicating that residual cancer cells likely remain within the surgical bed. A 'close margin' means cancer cells approach very near the edge—often defined as within one or two millimetres—without directly touching it. Margin status is conventionally codified as R0 (no residual tumour), R1 (microscopic residual tumour), or R2 (macroscopic residual tumour).

Why it matters

Margin status is one of the strongest predictors of whether a cancer will recur locally. A clear margin confirms that the operation achieved its local goal, significantly reducing the probability of disease returning in that specific area. Conversely, a positive or close margin signals an elevated risk of local relapse. This result fundamentally shapes post-operative treatment discussions, prompting the team to evaluate whether a re-excision is feasible or whether additional treatments like radiotherapy are warranted.

Related biomarkers and tests

Margin evaluation is a core element of histopathological analysis. The surgical specimen is marked on its outer surface with specialised indelible inks. Pathologists slice the specimen into thin cross-sections and examine them using light microscopy. They measure the exact distance in millimetres between the closest cancer cells and the inked edge. In some surgeries, real-time frozen section analysis is performed during the operation to guide immediate margin extension.

Related cancers

Resection margins are evaluated across almost all solid tumour operations. They are of critical prognostic value in breast cancer surgery, where obtaining clear margins during breast-conserving lumpectomy prevents mastectomy. Margin evaluation is equally crucial in skin melanoma, soft tissue sarcomas, colorectal resections, head and neck cancers, and radical prostatectomies for localised prostate carcinoma.

Related treatments

A clear margin (R0) allows a patient to proceed with standard adjuvant therapy or surveillance without further surgery. If margins are positive (R1/R2) or excessively close, the surgeon may perform a revision surgery to re-excise additional tissue from the wound bed. If re-operation is not possible due to anatomical boundaries, oncologists typically recommend adjuvant external beam radiotherapy or intensified systemic therapies to target remaining microscopic disease.

Frequently asked questions

What happens if my pathology report shows a positive margin?

A positive margin indicates that some cancer cells might have been left at the surgical boundary. Your multidisciplinary team will discuss the best course of action. If safe, your surgeon may recommend an additional minor operation to remove more tissue, or your radiation oncologist may deliver targeted radiation to clear residual cells.

What is the difference between a close margin and a clear margin?

A clear margin means there is a healthy band of normal tissue between the cancer and the edge of the specimen. A close margin means cancer cells approach very near the edge—often less than one or two millimetres—without touching it. Clinical guidelines dictate whether close margins require further treatment.

Can frozen section analysis prevent positive margins during surgery?

Frozen section analysis involves a rapid microscopic review of tissue while the patient remains in the operating room. While it can help surgeons immediately remove extra tissue if cancer is spotted, it is less comprehensive than final paraffin-embedded pathology, which provides the definitive margin verdict days later.

References

  1. 1.NCI Dictionary of Cancer Terms: MarginNational Cancer Institute
  2. 2.Understanding Your Pathology ReportAmerican Society of Clinical Oncology
  3. 3.ESMO Clinical Practice Guidelines: Breast CancerEuropean Society for Medical Oncology
GetOnco

Ask GetOnco AI

Get personalised answers about Resection Margin — Tissue Edge Around a Tumour from your AI cancer care coordinator.

GetOnco AI provides educational information and never replaces advice from your medical team.

Explore related topics

All Medical Glossary articlesExplore other categories
Medically reviewed by:GetOnco Medical Review Team — Oncology-trained clinicians and medical editors

Last reviewed August 1, 2026

Medical disclaimer

Educational information only. GetOnco is software, not a medical provider, and does not diagnose disease or recommend treatments. Always discuss your situation with qualified healthcare professionals.